MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 71 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,909 | -27.5% | 15,221 | +3.7% | 0.00% | -100.0% |
| Q2 2023 | $100,558 | -10.1% | 14,680 | +2.3% | 0.00% | 0.0% |
| Q1 2023 | $111,825 | +4.4% | 14,355 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $107,073 | -3.5% | 14,070 | +3.4% | 0.00% | 0.0% |
| Q3 2022 | $111,000 | -14.6% | 13,612 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $130,000 | -35.3% | 13,420 | -6.4% | 0.00% | 0.0% |
| Q1 2022 | $201,000 | +53.4% | 14,342 | +123.7% | 0.00% | 0.0% |
| Q4 2021 | $131,000 | -7.1% | 6,410 | +1.2% | 0.00% | 0.0% |
| Q3 2021 | $141,000 | – | 6,333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $12,029,000 | 7.99% |
| NEA Management Company, LLC | 7,703,205 | $62,935,000 | 3.14% |
| Cormorant Asset Management, LP | 2,993,717 | $24,459,000 | 1.71% |
| Alphabet Inc. | 1,464,015 | $11,961,000 | 0.61% |
| Avoro Capital Advisors LLC | 3,363,333 | $27,478,000 | 0.51% |
| Casdin Capital, LLC | 510,882 | $4,174,000 | 0.27% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,923,000 | 0.23% |
| Woodline Partners LP | 502,411 | $4,105,000 | 0.06% |
| Virtus Investment Advisers, Inc. | 12,638 | $103,000 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $230,000 | 0.04% |